US EditionCnio Pediatric Cancer Unit Award
Summary by CNIO
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CAR-T therapies are a type of personalized immunotherapy in which the patient’s defensive cells are modified in the laboratory to strengthen their ability to recognize and destroy tumor cells. Their use, increasingly frequent in adults, is still reduced in pediatrics. The European Society of Pediatric Oncology has already warned that the low incidence of childhood cancer “limits their commercial interest”, and has called for a regulatory environ…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
